BOCA RATON, Fla.--(BUSINESS WIRE)--Zero Gravity Solutions, Inc. (ZGSI or “the Company”), (Pink Sheets: ZGSI), announced today the introduction of BAM-FX™, a proprietary technology designed for use in the space program, which we are now developing and preparing to deploy for agricultural use on Earth to create densely nutritious, immune system enhancing food for application to world agriculture. Initial data utilizing our technology as applied to agricultural use on Earth has demonstrated, through independent certified laboratory analysis, the ability to systemically deliver targeted minerals and micronutrients throughout a plant from seed or root to maturity. This was accomplished without the use of genetic modification or traditional fertilizers. The ability to create highly nutritious, immune system enhanced crops that are not Genetically Modified Organisms (GMO) is a potentially significant, disruptive agricultural technology.
Harvey Kaye, chairman of the Company, stated, “Our six years of work on the International Space Station and the intellectual property we own has allowed us to introduce the first of an anticipated pipeline of technologies to help to feed the world.” Mr. Kaye further stated, “The commercial deployment of BAM-FX creates an executable path to revenue in the near term.”
Richard Godwin, the Company’s chief executive officer and president, stated, “During the next 12 months, the Company will be engaged in rigorous field testing in conjunction with end product users, foundations, governmental agencies and academia.” Mr. Godwin further added, “It is expected that peer-reviewed data resulting from this work will lead to final formulations, application methodologies, manufacturing, sales and distribution of this breakthrough technology.”
About Zero Gravity Solutions, Inc.
Zero Gravity Solutions, Inc. is a zero gravity biotechnology company whose mission is to commercialize, industrialize and monetize the unique capabilities of the ISS platform and low earth orbit. The Company is developing advances in plant, animal and human biology based on intellectual property designed for and derived from multiple experiments on the International Space Station. The Company owns intellectual property that is aimed at developing and producing large volumes of novel stem cells with unique and beneficial characteristics in a microgravity environment, without Genetic Modification techniques, which can then be patented for commercial sale to third parties in the agricultural and medical markets. The Company also owns proprietary technology for its first commercial product, BAM-FX™ that can boost the nutritional value and enhance the immune system of food crops without the use of Genetic Modification. ZGSI is headquartered in Boca Raton, Florida with offices and/or operations in Naperville, Illinois and Stevensville, Maryland. Information on the Company can be viewed on www.zerogsi.com.
This press release may contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, acceptance of the Company’s products, increased levels of competition for the Company, new products and technological changes, the Company’s dependence on third-party suppliers, and other risks detailed from time to time in the Company’s periodic reports filed with the Securities and Exchange Commission.